TGFβ acts as a potent inhibitor of proliferation and inducer of apoptosis in the early stages of breast cancer but promotes cancer aggressiveness through the induction of EMT and suppression of antitumor immune responses in advanced stages. Here, TGFB1 is linked to breast cancer.